Explain this page
Arphra AIPlain-English read on Revvity, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
B+Solid
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin53.1%
Operating margin12.5%
Net margin8.5%
ROE3.3%
ROA2.0%
ROIC3.3%
Liquidity & leverage
Current ratio1.68×
Quick ratio1.40×
Debt / equity0.48×
Net debt / EBITDA3.92×
Interest coverage4×
Efficiency & per-share
Asset turnover0.23×
Inventory days103
Days sales out.95
FCF / share$4.49
Book value / share$64.04
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | $13.66B | $10.99B | — | — | — | — |
| Enterprise value | — | — | — | $15.83B | $13.59B | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | 5.74 | 4.76 | — | — | — | — |
| EV / FCF | — | — | — | 29.22 | 26.74 | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | +2.17% | +2.20% | — | — | — | — |
| Free cash flow yield | — | — | — | +3.96% | +4.62% | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +59.62% | +53.16% | +48.07% | +48.01% | +53.08% | +48.64% | +48.62% | +48.93% | +48.51% |
| Operating margin | +35.01% | +23.59% | +14.52% | +14.90% | +12.49% | +14.17% | +14.25% | +14.20% | +13.71% |
| EBITDA margin | +42.25% | +35.71% | +25.94% | +30.50% | +23.20% | +26.70% | +26.26% | +26.49% | +27.34% |
| EBIT margin | +34.11% | +22.82% | +10.24% | +14.97% | +12.62% | +12.77% | +12.55% | +12.74% | +12.34% |
| Pre-tax margin | +31.44% | +19.68% | +6.65% | +11.47% | +9.39% | +9.16% | +9.34% | +9.35% | +9.32% |
| Net margin | +24.64% | +17.19% | -4.30% | +10.74% | +8.46% | +4.85% | +4.86% | +4.88% | +4.85% |
| Cost structure | |||||||||
| Cost of revenue / sales | +40.38% | +46.84% | +51.93% | +51.99% | +46.92% | +49.32% | +48.97% | +50.51% | +51.42% |
| R&D intensity | +5.23% | +6.69% | +7.87% | +7.14% | +7.56% | +7.67% | +7.58% | +7.33% | +7.59% |
| SG&A intensity | +19.37% | +22.89% | +25.67% | +25.96% | +33.10% | +27.72% | +28.79% | +29.05% | +27.42% |
| Effective tax rate | +26.10% | +21.35% | +1.90% | +10.46% | +9.62% | +7.17% | +6.98% | +7.06% | +7.00% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +13.21% | +7.71% | -1.50% | +3.86% | +3.33% | +1.81% | +1.75% | +1.78% | +1.77% |
| Return on assets (ROA) | +6.29% | +4.03% | -0.87% | +2.39% | +1.99% | +1.07% | +1.04% | +1.08% | +1.09% |
| Return on capital (ROC) | +10.89% | +6.52% | +3.35% | +3.73% | +3.31% | +3.52% | +3.48% | +3.48% | +3.37% |
| Return on invested capital (ROIC) | +7.67% | +4.75% | +2.51% | +2.69% | +2.24% | +1.21% | +1.19% | +1.20% | +1.19% |
| Asset turnover | +25.52% | +23.44% | +20.28% | +22.23% | +23.47% | +22.01% | +21.48% | +22.12% | +22.50% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +24.64% | +17.19% | -4.30% | +10.74% | +8.46% | +4.85% | +4.86% | +4.88% | +4.85% |
| Asset turnover (× revenue / assets) | +25.52% | +23.44% | +20.28% | +22.23% | +23.47% | +22.01% | +21.48% | +22.12% | +22.50% |
| Equity multiplier (× assets / equity) | +210.06% | +191.39% | +172.30% | +161.64% | +167.83% | +169.14% | +167.68% | +165.11% | +162.31% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.26 | 0.23 | 0.20 | 0.22 | 0.23 | 0.22 | 0.21 | 0.22 | 0.22 |
| Fixed-asset turnover | 5.89 | 4.93 | 4.14 | 4.24 | 4.43 | — | — | — | — |
| Inventory turnover | 3.63 | 3.83 | 3.34 | 3.90 | 3.53 | — | — | — | — |
| Receivables turnover | 5.41 | 5.40 | 4.35 | 4.36 | 3.84 | — | — | — | — |
| Payables turnover | 4.76 | 5.69 | 7.00 | 8.55 | 7.23 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 67.51 | 67.54 | 83.97 | 83.78 | 95.17 | — | — | — | — |
| Days inventory outstanding (DIO) | 100.56 | 95.41 | 109.38 | 93.67 | 103.37 | — | — | — | — |
| Days payables outstanding (DPO) | 76.69 | 64.20 | 52.16 | 42.67 | 50.52 | — | — | — | — |
| Cash conversion cycle | 91.37 | 98.75 | 141.20 | 134.78 | 148.02 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.50 | 1.19 | -0.77 | 2.12 | 2.41 | 3.19 | 3.14 | 3.18 | 3.26 |
| FCF / Net income | 1.40 | 1.04 | -0.08 | 1.83 | 2.10 | 2.54 | 2.55 | 2.59 | 2.52 |
| FCF margin | +34.61% | +17.94% | +0.36% | +19.66% | +17.80% | +12.34% | +12.42% | +12.64% | +12.24% |
| OCF margin | +36.86% | +20.53% | +3.32% | +22.81% | +20.37% | +15.49% | +15.25% | +15.50% | +15.80% |
| CapEx / Revenue | +2.25% | +2.59% | +2.96% | +3.15% | +2.57% | +2.90% | +2.91% | +2.92% | +2.96% |
| CapEx / D&A | 0.28 | 0.20 | 0.19 | 0.20 | 0.18 | — | — | — | — |
| Stock-based comp / Revenue | +0.78% | +1.56% | +1.51% | +1.37% | +0.80% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 8.08 | 4.50 | -0.95 | 2.41 | 2.08 | 5.24 | 5.83 | 6.46 | 6.88 |
| EPS · basic | 8.12 | 4.51 | -0.95 | 2.41 | 2.08 | 5.24 | 5.91 | 6.43 | 6.96 |
| Book value / share | 61.21 | 58.40 | 63.08 | 62.42 | 64.04 | 66.72 | 73.10 | 76.58 | 80.99 |
| Tangible BV / share | -28.35 | -19.59 | -13.49 | -11.71 | -15.11 | 66.72 | 73.10 | 76.58 | 80.99 |
| Sales / share | 32.81 | 26.20 | 22.04 | 22.43 | 25.23 | 24.84 | 26.33 | 27.97 | 29.58 |
| Operating CF / share | 12.09 | 5.38 | 0.73 | 5.12 | 5.14 | 3.85 | 4.02 | 4.34 | 4.67 |
| Free cash flow / share | 11.35 | 4.70 | 0.08 | 4.41 | 4.49 | 3.06 | 3.27 | 3.53 | 3.62 |
| Dividends / share | 0.28 | 0.28 | 0.28 | 0.28 | 0.29 | 0.31 | 0.32 | 0.35 | 0.36 |
| Payout ratio | +3.43% | +6.21% | -29.54% | +11.65% | +13.57% | +25.57% | +24.72% | +25.43% | +25.19% |
| Retention ratio | +96.57% | +93.79% | +129.54% | +88.35% | +86.43% | +74.43% | +75.28% | +74.57% | +74.81% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | -13.48% | -16.95% | +0.16% | +3.67% | -0.81% | +5.19% | +6.76% | +5.62% | -1.62% |
| Gross profit · YoY | — | -22.84% | -24.91% | +0.04% | +14.62% | -9.12% | +5.15% | +7.46% | +4.72% | -4.12% |
| Profit | ||||||||||
| Operating income · YoY | — | -41.71% | -48.86% | +2.76% | -13.13% | +12.52% | +5.82% | +6.38% | +1.99% | -12.49% |
| EBITDA · YoY | — | -26.86% | -39.67% | +17.76% | -21.13% | +14.12% | +3.48% | +7.70% | +8.99% | -6.82% |
| Net income · YoY | — | -39.65% | -120.80% | +349.91% | -18.31% | -43.14% | +5.44% | +7.17% | +5.00% | -19.70% |
| Operating | ||||||||||
| EBIT · YoY | — | -42.12% | -62.72% | +46.35% | -12.59% | +0.35% | +3.43% | +8.32% | +2.36% | -13.35% |
| R&D · YoY | — | +10.62% | -2.27% | -9.11% | +9.65% | +0.61% | +4.00% | +3.29% | +9.35% | +3.07% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | -44.31% | -121.09% | +353.87% | -13.69% | +152.15% | +11.14% | +10.87% | +6.38% | -2.00% |
| EPS · basic · YoY | — | -44.43% | -121.04% | +353.87% | -13.69% | +151.92% | +12.80% | +8.87% | +8.21% | -1.90% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $5.16B | $4.6B | $4.07B | $3.33B | $3.52B | $3.79B | $3.92B | $4.27B | $4.46B |
| Net debt | $4.56B | $4.14B | $3.15B | $2.16B | $2.6B | $2.78B | $2.85B | $3.12B | $3.22B |
| Net debt / EBITDA | 2.82 | 3.50 | 4.42 | 2.57 | 3.92 | 3.67 | 3.65 | 3.70 | 3.51 |
| Debt / equity | 0.72 | 0.62 | 0.52 | 0.43 | 0.48 | 0.50 | 0.47 | 0.49 | 0.49 |
| Debt / assets | +34.40% | +32.52% | +29.97% | +26.84% | +28.90% | +29.42% | +28.25% | +29.67% | +29.89% |
| Equity / assets | +47.61% | +52.25% | +58.04% | +61.87% | +59.58% | +59.12% | +59.64% | +60.57% | +61.61% |
| Coverage | |||||||||
| EBITDA / interest expense | 15.83 | 11.38 | 7.22 | 8.73 | 7.19 | 7.94 | 7.51 | 7.93 | 7.89 |
| Operating income / interest | 13.12 | 7.51 | 4.04 | 4.26 | 3.87 | 4.21 | 4.07 | 4.25 | 3.96 |
| Interest expense | $102.13M | $103.96M | $98.81M | $96.28M | $92.19M | $95.23M | $104.23M | $106.35M | $116.37M |
| Liquidity | |||||||||
| Current ratio | 2.01 | 2.13 | 2.07 | 3.60 | 1.68 | — | — | — | — |
| Quick ratio | 1.08 | 0.69 | 1.54 | 2.75 | 1.25 | — | — | — | — |
| Cash ratio | 0.50 | 0.29 | 0.63 | 1.78 | 0.69 | — | — | — | — |
| Working capital | $1.23B | $1.74B | $1.55B | $1.7B | $908.5M | — | — | — | — |
| Working capital / revenue | +32.06% | +52.66% | +56.37% | +61.58% | +31.81% | — | — | — | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | 4.76x | 5.74x |
| Earnings yield | 2.2% | 2.2% |
| FCF yield | 4.6% | 4.0% |
Returns
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | 3.3% | 3.9% |
| ROA | 2.0% | 2.4% |
| ROIC | 2.8% | 3.1% |
Leverage & liquidity
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | 3.92 | 2.57 |
| Interest coverage | — | — |
| Current ratio | 1.68x | 3.60x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).